Sollis Health San Francisco

Summary Statement of Deficiencies D0000 A proficiency testing desk review survey as performed on 11/21/2025, the laboratory was found not in compliance with the following CONDITION LEVEL DEFICIENCIES D2016 - 42 C.F.R. 493.803 Condition: Successful [proficiency testing] participation; and D6000 - 42 C.F.R. 493.1403 Condition: Laboratories performing moderate complexity testing; laboratory director. D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) - 0155D and American Proficiency Institute records (2025-2 and 2025-3), the laboratory failed to successfully participate in a proficiency testing program Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- approved by HHS for each specialty, subspecialty and analyte or test in which the laboratory is certified under CLIA, the laboratory failed to successfully participate in the analyte CK, Total resulting in an unsuccessful performance. See D2096. D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) (f) Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of the Certification and Survey Provider Enhanced Reporting (CASPER) Report 0155D Individual Laboratory Profile and American Proficiency Institute report, the laboratory failed to achieve satisfactory performance for two of three consecutive proficiency events (2025-2 and 2025-3) for the analyte CK, Total. The finding include: CK, Total 60% - 2025 second testing event; CK, Total 40% - 2025 third testing event. A review of the 2025 scores from American Proficiency Institute confirmed the above findings. D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on a proficiency testing desk review of the CASPER 0155D report and American Proficiency Institute records for 2025-2 and 2025-3 events, the laboratory director failed to provide overall management and direction of the laboratory services. Refer to D6016. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) (e)(4)(i) The proficiency testing samples are tested as required under Subpart H of this part; This STANDARD is not met as evidenced by: Based on a proficiency testing desk review of the CASPER 0155D report and American Proficiency Institute records for 2025-2 and 2025-3 events, the laboratory director failed to ensure successful participation in an HHS proficiency testing program. Refer to D2096. -- 2 of 2 --

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of personnel competency assessment records, review of Ten (10) randomly selected patient test results and interview with the Technical Consultant (TC), the laboratory failed to assess employee competency. The findings include: 1. It was the practice of the laboratory to perform General Immunology, Routine Chemistry and Hematology testing. The Laboratory Technicians and Nurse Practitioners were responsible for performing daily maintenance and function check. 2- The laboratory's Technical Consultant affirmed on April 17, 2025, at approximately 12:00 pm, that the laboratory maintained no documentation for the competency assessments for 14 of 16 Testing personnels. 3- The laboratory's testing declaration form, signed by the laboratory director on April 17, 2025, stated that the laboratory performed approximately 2360 tests annually. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) (d)(10) Establish or verify the criteria for acceptability of all control materials. (d)(10) (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (d)(10)(ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (d)(10)(iii) Statistical parameters for unassayed control materials Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. This STANDARD is not met as evidenced by: Based on interview with the Technical Consultant (TC) on April 17, 2025, and review of Chemistry Quality Control (QC) records from 09/10/2024 through 04/17/2025, the laboratory failed to verify the stated values of the commercially assayed chemistry QC materials in use at the time of the survey. The findings include: 1. It was the practice of the laboratory to use NOVA-ONE commercially assayed chemistry QC materials to monitor patient chemistry testing using Piccolo analyzer. The TC stated that the laboratory switched the QC materials from the old lot # 528223003 to the new lot number of lot# 528024002 on 09/10/2024. 2. The laboratory maintained no documentation to indicate the stated values of chemistry QC materials lot number 528024002 had been verified for Piccolo analyzer by the laboratory prior to testing patient samples. 3. On Aril 17, 2025, at approximately 11:00 am, the technical consultant affirmed that the laboratory did not verify the value of QC materials provided by the manufacturer. 4. The laboratory did not verify the Chemistry QC materials for 8 of 8 months. The laboratory's testing declaration form, signed by the laboratory director on April 17, 2025, stated that the laboratory performed 1650 chemistry tests annually. D6036 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413 The technical consultant is responsible for the technical and scientific oversight of the laboratory. The technical consultant is not required to be onsite at all times testing is performed; however, he or she must be available to the laboratory on an as needed basis to provide consultation, as specified in paragraph (a) of this section. This STANDARD is not met as evidenced by: Based on review of personnel competency assessment record, chemistry quality control record, review of Ten (10) randomly selected patient test results, and interview with the Technical Consultant (TC) on April 17, 2025, it was determined that the TC failed to provide technical and scientific consultation to the laboratory. The findings include: 1. The Laboratory failed to verify the manufacturer-established values of the commercially assayed chemistry QC materials of the new QC lot. See D5469. 2. The laboratory failed to follow written policies and procedures to assess testing personnel competency. See D5209 -- 2 of 2 --